Novartis becomes the second company to settle after being accused of reaping rewards from a racist medical system.

Qualifications either matter — for everyone — or they do not. Confirming an unlicensed nominee signals that standards are ...

Minnesota hospitals and clinics participating in a controversial U.S. drug discount program reaped at least $1.34 billion in ...

SEC filings show that, at least for some drugmakers, "most-favored nation" drug pricing deals with President Trump last three ...

For too long, the promise of personalized therapies has been tantalizingly close, yet frustratingly out of reach for ...

Scoop: Cigna has acquired CarepathRx, a large pharmacy backed by private equity that dispenses prescription drugs to nearly ...

It’s high time to change this and focus on sexual and reproductive health for men. Every single unplanned pregnancy involves ...

The order aims to shore up production of the herbicide glyphosate (better known as the active ingredient in the weed killer Roundup) for “national security and defense reasons.” And many in the Make ...

Kennedy said in a statement that Sean G. Downing, a primary care doctor licensed in Florida, and Angelina Farella, a pediatrician in Texas, would join the Advisory Committee on Immunization Practices, ...

FDA Commissioner Marty Makary defended the agency’s recent rejections of rare disease drugs and one of his deputies, Vinay ...

Exclusive: Harvard geneticist George Church knew more about Jeffrey Epstein's activities than he has previously said, before ...

Xenon Pharmaceuticals is developing a drug for the most common type of seizure experienced by people with epilepsy. Here's ...